Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Recent advances in molecular medicine techniques for the diagnosis, prevention, and control of infectious diseases.

Fran├ža RF, da Silva CC, De Paula SO.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):723-8. doi: 10.1007/s10096-013-1813-0. Epub 2013 Jan 22. Review.

PMID:
23339016
2.

[Infectious diseases--new horizons].

Spirer Z, Barzilai A.

Harefuah. 2012 Aug;151(8):483-7, 496. Review. Hebrew.

PMID:
23350296
3.

New adjuvants for human vaccines.

Mbow ML, De Gregorio E, Valiante NM, Rappuoli R.

Curr Opin Immunol. 2010 Jun;22(3):411-6. doi: 10.1016/j.coi.2010.04.004. Epub 2010 May 11. Review.

PMID:
20466528
5.

Threat of infection: microbes of high pathogenic potential--strategies for detection, control and eradication.

Hammerschmidt S, Hacker J, Klenk HD.

Int J Med Microbiol. 2005 Jun;295(3):141-51.

PMID:
16044855
6.

Glycan arrays as tools for infectious disease research.

Geissner A, Anish C, Seeberger PH.

Curr Opin Chem Biol. 2014 Feb;18:38-45. doi: 10.1016/j.cbpa.2013.11.013. Epub 2013 Dec 30. Review.

PMID:
24534751
7.

Emerging infectious disease: global response, global alert.

Nakajima H.

Health Millions. 1997 Mar-Apr;23(2):19.

PMID:
12348002
8.

From Pasteur to genomics: progress and challenges in infectious diseases.

Rappuoli R.

Nat Med. 2004 Nov;10(11):1177-85.

PMID:
15516917
9.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
10.

Rapid molecular theranostics in infectious diseases.

Picard FJ, Bergeron MG.

Drug Discov Today. 2002 Nov 1;7(21):1092-101. Review.

PMID:
12546841
11.

[Vaccines for the future].

Girard MP.

Ann Pharm Fr. 2009 May;67(3):203-12. doi: 10.1016/j.pharma.2009.02.004. Epub 2009 Mar 27. Review. French.

PMID:
19446671
12.

Implications of new technology for infectious diseases practice.

Baron EJ.

Clin Infect Dis. 2006 Nov 15;43(10):1318-23. Epub 2006 Oct 10.

PMID:
17051500
13.

New approaches in vaccine development.

Leclerc C.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):329-41. Review.

PMID:
12818620
14.
15.
16.

From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.

Mortellaro A, Ricciardi-Castagnoli P.

Immunol Cell Biol. 2011 Mar;89(3):332-9. doi: 10.1038/icb.2010.152. Epub 2011 Feb 8. Review.

PMID:
21301476
17.

Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe.

Read RC, Cornaglia G, Kahlmeter G; European Society of Clinical Microbiology and Infectious Diseases Professional Affairs Workshop group..

Lancet Infect Dis. 2011 May;11(5):408-15. doi: 10.1016/S1473-3099(10)70294-2. Review.

PMID:
21530895
18.

[Laboratory tests for infectious diseases and medical reimbursement].

Shimetani N.

Rinsho Byori. 2002 May;50(5):474-8. Japanese.

PMID:
12078044
19.
20.

Infectious disease emergencies: role of the infectious disease specialist.

Norrby SR.

Clin Microbiol Infect. 2005 Apr;11 Suppl 1:9-11. Review.

PMID:
15816100

Supplemental Content

Support Center